Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Retained Earnings (2021 - 2025)

Historic Retained Earnings for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to -$108.4 million.

  • Coeptis Therapeutics Holdings' Retained Earnings fell 1381.4% to -$108.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$108.4 million, marking a year-over-year decrease of 1381.4%. This contributed to the annual value of -$98.0 million for FY2024, which is 1222.63% down from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Retained Earnings of -$108.4 million as of Q3 2025, which was down 1381.4% from -$106.0 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Retained Earnings ranged from a high of -$3.2 million in Q1 2021 and a low of -$108.4 million during Q3 2025
  • Its 5-year average for Retained Earnings is -$57.9 million, with a median of -$75.6 million in 2023.
  • In the last 5 years, Coeptis Therapeutics Holdings' Retained Earnings soared by 1881.67% in 2022 and then tumbled by 195363.98% in 2023.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Retained Earnings (Quarter) stood at -$27.6 million in 2021, then crashed by 139.89% to -$66.1 million in 2022, then plummeted by 32.18% to -$87.4 million in 2023, then fell by 12.23% to -$98.0 million in 2024, then fell by 10.55% to -$108.4 million in 2025.
  • Its last three reported values are -$108.4 million in Q3 2025, -$106.0 million for Q2 2025, and -$101.7 million during Q1 2025.